Short interest | 11.48% |
As a Free StocksGuide user, you can view scores for all 6,907 stocks worldwide.
+/-
%
|
|||
Revenue | - - |
-
|
|
Gross Profit | - - |
-
|
|
EBITDA | - - |
-
|
EBIT (Operating Income) EBIT | - - |
-
|
Net Profit | - - |
-
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
EyeGate Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes EGP-437 and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.
Head office | United States |
CEO | Brian Strem |
Founded | 1998 |
Website | www.kiorapharma.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.